Medical Marketing & Media: Biologic/Biosimilar & Lupus Markets News, Steve Gauldie PostsBack Bay Life Science AdvisorsApril 26, 2017
Bloomberg Baystate Business Hour: Precision Medicine Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsApril 19, 2017Precision Medicine
Healthcare Innovation News: Building a Culture of Innovation Michelle Hoffmann Posts, NewsBack Bay Life Science AdvisorsApril 11, 2017Innovation
Becker's Hospital Review - Biosimilar Market News, Steve Gauldie PostsStephen Gauldie, PhDMarch 23, 2017
Life Science Leader - Academia Finds New Ways To Partner With Pharma Chris Leo Posts, Jonathan Gertler Posts, NewsChristopher Leo, PhD March 8, 2017
Acquiror or Acquiree? The Role of M&A "Deal Heat" in Premium Valuations Blog, Greg Benning Posts, Jonathan Gertler Posts, NewsInvestment Banking TeamMarch 1, 2017
Scrip Pharma Intelligence: Orphan Drug Pricing News, Steve Gauldie PostsBack Bay Life Science AdvisorsFebruary 28, 2017Orphan Drug Development, Pricing
Scrip Pharma: Deal Watch: Best Value for Smaller Firms Lies in the Back End News, Vasilios Kofitsas PostsInvestment Banking TeamFebruary 7, 2017Biopharma Financing, Investment Banking, Transactions
Drug Pricing: Asking the Right Questions Blog, News, Vasilios Kofitsas PostsBack Bay Life Science AdvisorsFebruary 7, 2017Drug Pricing, Innovation, Drug Development, Pharmacutical
Xconomy: Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsFebruary 2, 2017M&A, Boston Life Science Ecosystem
Back Bay in the Boston Globe: Challenge for Cancer Drug Startups Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsJanuary 27, 2017Drug Development, Oncology, Boston Life Science Ecosystem, Emerging Biotech
Back Bay in Wall Street Journal Newsletter: Biotech M&A Deals Expected to Increase Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsJanuary 17, 2017M&A, Investment Banking, Life Science IPOs
Positive Prognosis for The 21st Century Cures Act Michelle Hoffmann Posts, NewsBack Bay Life Science AdvisorsJanuary 10, 2017Clinical Regulatory
Back Bay in US News and World Report: Biggest Financial Headlines of 2016 Jonathan Gertler Posts, News, Back Bay in the NewsBack Bay Life Science AdvisorsJanuary 3, 2017Investment Banking, Biotech Financing
Scrip Intelligence: Early-Stage Funding Slips Again (VC Roundup) Back Bay in the News, NewsBack Bay Life Science AdvisorsDecember 9, 2016VC, Investment Banking, Biotech Funding
STAT: Reviving Optimism for Regenerative Medicine NewsBack Bay Life Science AdvisorsNovember 18, 2016Regenerative Medicine
Back Bay Life Science Advisors to Moderate MassBio Panel on Valuation & Funding Events, NewsInvestment Banking TeamNovember 1, 2016
Back Bay Rowers Take Four First Place Medals at The Head of the Charles Regatta Blog, NewsBack Bay Life Science AdvisorsOctober 25, 2016
Back Bay in the Boston Globe: Crispr IPO Doesn't Hit It's Target News, Back Bay in the NewsBack Bay Life Science AdvisorsOctober 24, 2016Gene Editing, IPO, Investment Banking
100 Years Later, Legacy of Patient Care Carries Us Forward Blog, Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsOctober 19, 2016
